Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients door Cloud P. Paweletz (14960112)

Onderwerpen:

Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... door Stephanie Lheureux (16797697)

Onderwerpen:

Supplementary Table S5 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... door Stephanie Lheureux (16797697)

Onderwerpen:

Supplementary Table S3 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... door Stephanie Lheureux (16797697)

Onderwerpen:

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... door Stephanie Lheureux (16797697)

Onderwerpen:

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP... door Stephanie Lheureux (16797697)

Onderwerpen:

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation door Francesca Orzan (15055579)

Onderwerpen:

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation door Francesca Orzan (15055579)

Onderwerpen:

Integrating urinary metabolomics and clinical datasets for multi-cancer detection door Dongyong Lee (18786694)

Onderwerpen:

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation door Francesca Orzan (15055579)

Onderwerpen:

Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... door Kala Visvanathan (14952973)

Onderwerpen:

Supplementary Figure S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... door Kala Visvanathan (14952973)

Onderwerpen:

Supplementary Figure S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... door Kala Visvanathan (14952973)

Onderwerpen:

Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... door Kala Visvanathan (14952973)

Onderwerpen:

Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros... door Kala Visvanathan (14952973)

Onderwerpen:

Figure 6 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer door Martin Sjöström (14845882)

Onderwerpen:

Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer door Martin Sjöström (14845882)

Onderwerpen:

Figure 4 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer door Martin Sjöström (14845882)

Onderwerpen:

Supplementary Data 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer door Whitney L. Hensing (16461978)

Onderwerpen:

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer door Martin Sjöström (14845882)

Onderwerpen: